This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Sep 22;392(10152):988-990.

doi: 10.1016/S0140-6736(18)31990-1. Epub 2018 Aug 26.

Aspirin for primary prevention of cardiovascular disease

Davide Capodanno¹, Dominick J Angiolillo²

Affiliations

Affiliations

¹ Division of Cardiology, AOU "Policlinico Vittorio Emanuele", PO Rodolico, Catania 95123, Sicily, Italy. Electronic address: dcapodanno@gmail.com.
² Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.

PMID: 30158070
DOI: 10.1016/S0140-6736(18)31990-1

Comment

Aspirin for primary prevention of cardiovascular disease

Davide Capodanno et al. Lancet. 2018.

. 2018 Sep 22;392(10152):988-990.

doi: 10.1016/S0140-6736(18)31990-1. Epub 2018 Aug 26.

Authors

Davide Capodanno¹, Dominick J Angiolillo²

Affiliations

¹ Division of Cardiology, AOU "Policlinico Vittorio Emanuele", PO Rodolico, Catania 95123, Sicily, Italy. Electronic address: dcapodanno@gmail.com.
² Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.

PMID: 30158070
DOI: 10.1016/S0140-6736(18)31990-1

No abstract available

PubMed Disclaimer

Comment on

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.

Similar articles

[The role of aspirin in the primary prevention of cardiovascular disease].
Rodondi N, Cornuz J. Rodondi N, et al. Rev Med Suisse. 2006 Mar 8;2(56):646-51. Rev Med Suisse. 2006. PMID: 16597054 Review. French.
[Aspirin and primary prevention of cardiovascular diseases in the elderly].
Manríquez M, Vallano A. Manríquez M, et al. Rev Esp Geriatr Gerontol. 2009 Nov-Dec;44(6):349-51. doi: 10.1016/j.regg.2009.06.001. Epub 2009 Sep 1. Rev Esp Geriatr Gerontol. 2009. PMID: 19726108 Spanish. No abstract available.
Aspirin in the primary prevention of cardiovascular disease.
Galloway CF, Stevenson JC. Galloway CF, et al. Maturitas. 2011 Jan;68(1):3-4. doi: 10.1016/j.maturitas.2010.09.011. Epub 2010 Dec 15. Maturitas. 2011. PMID: 21111550 No abstract available.
[Aspirin for primary cardiovascular disease prevention - an update].
De Caterina R. De Caterina R. G Ital Cardiol (Rome). 2017 Jan;18(1):1-6. doi: 10.1714/2628.27020. G Ital Cardiol (Rome). 2017. PMID: 28287208 Italian. No abstract available.
Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
U.S. Preventive Services Task Force. U.S. Preventive Services Task Force. Am J Nurs. 2002 Mar;102(3):67, 69-70. Am J Nurs. 2002. PMID: 11976531 Review. No abstract available.

See all similar articles

Cited by

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
Sehanobish E, Asad M, Barbi M, Porcelli SA, Jerschow E. Sehanobish E, et al. Front Immunol. 2021 Jun 25;12:695815. doi: 10.3389/fimmu.2021.695815. eCollection 2021. Front Immunol. 2021. PMID: 34305932 Free PMC article. Review.
Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification.
Doneen AL, Bale BF, Vigerust DJ, Leimgruber PP. Doneen AL, et al. Front Cardiovasc Med. 2020 May 22;7:92. doi: 10.3389/fcvm.2020.00092. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32528979 Free PMC article.
Low-Dose Aspirin Treatment Attenuates Male Rat Salt-Sensitive Hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway.
Jiang X, Liu X, Liu X, Wu X, Jose PA, Liu M, Yang Z. Jiang X, et al. J Am Heart Assoc. 2020 Jan 7;9(1):e013470. doi: 10.1161/JAHA.119.013470. Epub 2019 Dec 19. J Am Heart Assoc. 2020. PMID: 31852420 Free PMC article.
Aspirin in primary prevention: the triumph of clinical judgement over complex equations.
Santilli F, Simeone P. Santilli F, et al. Intern Emerg Med. 2019 Nov;14(8):1217-1231. doi: 10.1007/s11739-019-02191-4. Epub 2019 Sep 21. Intern Emerg Med. 2019. PMID: 31542891 Review.
Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injury.
Zhou X, Wu Y, Ye L, Wang Y, Zhang K, Wang L, Huang Y, Wang L, Xian S, Zhang Y, Chen Y. Zhou X, et al. Acta Pharm Sin B. 2019 Jul;9(4):711-723. doi: 10.1016/j.apsb.2019.02.008. Epub 2019 Feb 28. Acta Pharm Sin B. 2019. PMID: 31384532 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- scite Smart Citations